Wilrijk, Belgium

Jan Van Deun

This inventor holds 1 USPTO granted patent. Top assignee: The General Hospital Corporation. Active years: 2026.


Average Co-Inventor Count = 1.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Jan Van Deun: Innovator in Chromatography for Extracellular Vesicles

Introduction

Jan Van Deun is a notable inventor based in Wilrijk, Belgium. He has made significant contributions to the field of chromatography, particularly in the purification of extracellular vesicles (EVs) from plasma. His innovative approach has the potential to enhance research and clinical applications involving EVs.

Latest Patents

Jan Van Deun holds a patent for "Integrated dual-mode chromatography to enrich extracellular vesicles from plasma." This patent describes devices, methods, and kits for purifying EVs using size exclusion chromatography in tandem with cation exchange chromatography, a technique referred to as dual-mode chromatography (DMC). This advancement is crucial for improving the efficiency and effectiveness of EV purification.

Career Highlights

Throughout his career, Jan has focused on developing innovative solutions in the field of chromatography. His work has been instrumental in advancing the understanding and application of extracellular vesicles in various scientific domains. He is associated with The General Hospital Corporation, where he continues to contribute to groundbreaking research.

Collaborations

Jan Van Deun has collaborated with esteemed colleagues, including Hakho Lee and Ralph Weissleder. These partnerships have fostered a collaborative environment that enhances the development of innovative technologies in the field.

Conclusion

Jan Van Deun is a prominent inventor whose work in chromatography has the potential to significantly impact the purification of extracellular vesicles. His contributions are paving the way for advancements in research and clinical applications.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…